Sitagliptin Use in Patients With Diabetes and Heart Failure: A Population-Based Retrospective Cohort Study

Study Questions:

What are the effects of sitagliptin, a dipeptidyl peptidase (DPP)-4 inhibitor, in patients with type 2 diabetes mellitus (T2DM) and incident heart failure (HF)?